The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of induction Erlotinib followed by chemotherapy with Platinum + Pemetrexed +/- Bevacizumab for EGFR mutation-positive non-squamous non-small cell lung cancer patients.
 
Tetsuo Tani
No Relationships to Disclose
 
Kenzo Soejima
No Relationships to Disclose
 
Katsuhiko Naoki
No Relationships to Disclose
 
Daisuke Arai
No Relationships to Disclose
 
Kouta Ishioka
No Relationships to Disclose
 
Keiko Ohgino
No Relationships to Disclose
 
Makoto Nishino
No Relationships to Disclose
 
Aoi Kuroda
No Relationships to Disclose
 
Hiroyuki Yasuda
No Relationships to Disclose
 
Tomoko Betsuyaku
No Relationships to Disclose